CoChat

No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon‐like‐peptide‐1 administration in fasting healthy subjects

Lerche, Susanne, Soendergaard, Liselotte, Rungby, Joergen, Moeller, Niels, Holst, Jens Juul, Schmitz, Ole E., Brock, Birgitte · 2009 · Clinical Endocrinology
Cited by 26

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Summary: Objective It is uncertain whether the ability to avoid hypoglycaemia during fasting is preserved, and the risk of reactive hypoglycaemia after an oral glucose stimulus following a prolonged fasting period is increased at augmented glucagon‐like peptide‐1 (GLP‐1) levels. Design A randomized, double‐blind placebo‐controlled cross‐over study in eight healthy men to assess the safety, in terms of hypoglycaemia, of a continuously infused pharmacological dose of native GLP‐1 during long‐term fasting. After an overnight fast the fasting period continued for 48 h and was followed by a 3‐h oral glucose tolerance test (OGTT). GLP‐1(7‐36 amide) or placebo was continuously infused subcutaneously and titrated to a dose of 4·8 pmol/kg per min. Results Two subjects in the GLP‐1 group and one subject in the placebo group were withdrawn due to protocol specified plasma glucose (PG) ≤ 2·8 m m and neuroglycopaenic symptoms. The infusion of GLP‐1 resulted in pharmacological levels of intact GLP‐1. During the fasting period PG, insulin and C‐peptide levels declined and glucagon, GH and free fatty acid (FFA) levels increased with no differences between GLP‐1 and placebo. During OGTT circulating levels of insulin and C‐peptide were higher with GLP‐1 infusion. However, PG was similar during GLP‐1 vs. placebo infusions. GLP‐1 infusion increased norepinephrine and cortisol levels during OGTT. Conclusion The counter‐regulatory response during 48 h of subcutaneous GLP‐1 infusion was preserved despite long‐term fasting with no apparent increased risk of hypoglycaemic episodes. No reactive hypoglycaemia was observed when the fast was followed by an OGTT. Thus use of long‐acting GLP‐1 analogues may not increase the risk of hypoglycaemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2008.03510.x

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 26

Metadata

Authors
Lerche, S., Soendergaard, L., Rungby, J., Moeller, N., Holst, J. J., Schmitz, O. E., & Brock, B.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2009-09-07
Volume
71
Issue
4
Pages
500-506
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2135134545
Cited by
26
References
14
FWCI
1.09
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon‐like‐peptide‐1 administration in fasting healthy subjects. https://app.cochat.ai/papers/10.1111/j.1365-2265.2008.03510.x
The paper
Lerche, S., Soendergaard, L., Rungby, J., Moeller, N., Holst, J. J., Schmitz, O. E., & Brock, B. (2009). No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon‐like‐peptide‐1 administration in fasting healthy subjects. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2008.03510.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.